Antixenosis and antibiosis in the resistance of common beans (Phaseolus vulgaris L.) to the melon thrips, Thrips palmi Karny, were investigated under laboratory and field conditions. Experiments were conducted for four moderately resistant genotypes (‘Brunca’, BH-130, EMP 486, and FEB 115) in comparison with one susceptible genotype (APN 18). Multiple-choice tests recorded most thrips on EMP 486 and least on FEB 115. Dual-choice tests conducted in both laboratory and field confirmed the antixenotic effect of FEB 115 and the attractant effect of EMP 486 on thrips. These results demonstrate the significance of antixenosis in the resistance of common beans to T. palmi. Life-table studies showed significant differences in egg duration, immature and adult survivorship, female body length and longevity, daily oviposition rate, and total fecundity among the bean genotypes. The intrinsic rate of natural increase (rm) and its associated population parameters varied significantly with the bean genotype on which T. palmi cohorts were reared. Based on mean rm values, the five bean genotypes can be divided into two groups, with BH-130 and ‘Brunca’ being less favorable for the population growth of thrips than EMP 486 and FEB 115; the latter were comparable to the susceptible genotype APN 18. These life-table results indicate the role of antibiosis in enhancing the resistance of common beans to T. palmi.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.